Skip to content

Effect of adding ketamine infusion to propofol sedation on hemodynamic changes and recovery in patients undergoing elective lower limb surgery under spinal anaesthesia

Addition of ketamine infusion to propofol sedation with spinal anesthesia in patients undergoing elective lower limb surgery: Hemodynamic changes, Recovery Profile

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000372583
Enrollment
61
Registered
2015-04-23
Start date
2014-07-07
Completion date
2014-10-06
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We tried to evaluate the difference between two sedation drugs with the route of ; propofol alone intravenous infusion and ketamine-propofol combined intravenous infusion. We studied during lower limb surgery with spinal anesthesia. And observed patients hemodynamic values, mini mental state examination scores, postoperative events, satisfaction scores.

Interventions

Intravenous infusions of propofol alone and ketamine combined with propofol during sedation. In group P: Propofol infusion dose is 25-75 mcg/kg/min and titrated according to Ramsey Sedation Score. In group KP: Propofol was managed like in Group P and ketamine dose is 1/3 of propofol in terms of mg.

Sponsors

Aysu Hayriye Tezcan
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Caregiver)

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

25-80 years old Both gender Candidate of elective lower limb surgery Do not have contraindications for spinal anesthesia

Exclusion criteria

Patients with a allergic reaction to propofol or ketamine, obesity (BMI greater than or equal to 35)  , uncontrolled hypertension ( greater than 170/100mmHg), clinically significant cardiac, pulmonary, hepatic, renal dysfunction, psychiatric disorders, neurologic impairment were exluded from study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026